Medexus
Toronto, CA · 109 employees on LinkedIn · 1 known investors
Medexus Pharmaceuticals is a specialty pharmaceutical company focused on orphan drugs and rare disease treatments, with a portfolio of specialty and rare disease products. It operates a fully integrated North American business model spanning commercial operations, supply chain, regulatory, medical affairs, and sales.
Investors · 1
Competitors · 2
by search overlapWalgreens44 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
BiPar Sciences44 shared keywordsBiopharmaceutical developer of tumor-selective PARP inhibitor cancer therapies, acquired by Sanofi-aventis in 2009.
Companies competing with Medexus for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Medexus do?
- Medexus Pharmaceuticals is a specialty pharmaceutical company focused on orphan drugs and rare disease treatments, with a portfolio of specialty and rare disease products. It operates a fully integrated North American business model spanning commercial operations, supply chain, regulatory, medical affairs, and sales.
- Who are Medexus's investors?
- Medexus's investors include Lumira Ventures.
- Where is Medexus headquartered?
- Medexus is headquartered in Toronto, CA.